3/5bluebird bio, Inc. (BLUE): Going-concern doubt

Market data

Price before filing: $3.31 (2025-05-13 close, split/dividend-adjusted)
Market cap at flag: $48.6M (2025-05-14) · Latest: $48.5M (2025-06-02)

What happened next

Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.

Verified excerpt

"The Company's history of recurring operating losses and negative operating cash flows, its expectation to generate operating losses and negative operating cash flows, its projection that it may not maintain the minimum cash coverage related to the Loan and Security Agreement (the "LSA"), and the need for additional funding to support its planned operations raise substantial doubt regarding the Company's ability to..."

Quoted from the filing. Source

What this means

The filing states that substantial doubt exists about the company's ability to continue as a going concern: it may not have enough cash to last the next 12 months. Expect dilution, debt deals or worse. An auditor's going-concern paragraph is the strongest form of this warning.

Source: management disclosure in Form 10-Q (period 2025-03-31)

Why this score: quarterly (unaudited) disclosure